Madeline Merrill, MS

I’m a board-certified nurse practitioner (NP) who is part of the Early Drug Development Service at Memorial Sloan Kettering Cancer Center (MSK). In this role, I care for people who are part of early-stage clinical trials. These trials test if new treatments such as immunotherapy and targeted therapies are safe and effective for treating solid tumors.

I have more than 15 years of experience in caring for people with cancer and other complex medical conditions. I work to expand access to the latest cancer treatments and improve the patient experience through the clinical trial journey. I’m also an education specialist, leading onboarding and training programs for Advanced Practice Providers (APPs) and nurses across MSK.

I’m currently pursuing a PhD in nursing at CUNY Hunter College. My research focuses on equality in access to healthcare and the use of artificial intelligence in cancer care.

My goal is to combine clinical excellence, research, and innovation to help people navigate cancer treatment with greater confidence and support. I’m passionate about finding new treatments for cancer and love being a part of the latest science at MSK.